traumatic brain injury and other brain disorders brain... · ©2015 mfmer | slide-1 traumatic brain...

©2015 MFMER | slide-1

Traumatic Brain Injury and Other Brain Disorders

• Billie A Schultz, MD is a Consultant in the Department of Physical Medicine and Rehabilitation at the Mayo Clinic in Rochester, MN

• Dr. Schultz is an Assistant Professor in the College of Medicine.

• She is board certified in PM&R and subspecialty certified in Brain Injury Medicine

• Clinical interests include acquired brain injury and spasticity

Mayo Clinic Physical Medicine and Rehabilitation Board Review

©2015 MFMER | slide-2

Traumatic Brain Injury and Other Brain Disorders Online curriculum

Billie A Schultz, MD

Physical Medicine and Rehabilitation Board Review

©2015 MFMER | slide-3

Disclosures • Financial- None • Off Label usage of medications will be

discussed in management of TBI associated complications

©2015 MFMER | slide-4

Objectives • Identify common TBI related symptoms and

management • Identify various presentations and interventions

of other brain related disorders including multiple sclerosis and Parkinson Disease

©2015 MFMER | slide-5

Traumatic Brain injury- Definition • Injury to the brain caused by external forces

• Does not require loss of consciousness • Does not require direct impact to the head

©2015 MFMER | slide-6

Cause of TBI All Ages

Falls

Motor Vehicle-TrafficViolence

Struck by/ Against

Unknown/Other

Mayo Clinic Physical Medicine and Rehabilitation Board Review

CDC, 2014

©2015 MFMER | slide-7

Cause of TBI Ages 0-4

Falls

Motor Vehicle-TrafficViolence

Struck by/ Against

Unknown/Other

Mayo Clinic Physical Medicine and Rehabilitation Board Review

CDC, 2014

©2015 MFMER | slide-8

Cause of TBI Ages 65 and greater

Falls

Motor Vehicle-TrafficViolence

Struck by/ Against

Unknown/Other

Mayo Clinic Physical Medicine and Rehabilitation Board Review

CDC, 2014

©2015 MFMER | slide-9

Cause of TBI Ages 25-44

Falls

Motor Vehicle-TrafficViolence

Struck by/ Against

Unknown/Other

Mayo Clinic Physical Medicine and Rehabilitation Board Review

CDC, 2014

©2015 MFMER | slide-10

Gender distribution of TBI based on ED visits in 2010

MenWomen

Mayo Clinic Physical Medicine and Rehabilitation Board Review

CDC, 2014

©2015 MFMER | slide-11

TBI- pathophysiology • Primary Injury

• Direct result of trauma • Contusion/lacerations

• Common location of contusions • Inferior frontal lobe • Anterior temporal lobe

• Diffuse axonal injury • Common location of DAI

• Midline brain structures • Grey-white matter junctions

• Cranial nerve injury • Diffuse vascular injury • Focal intracranial hemorrhage

©2015 MFMER | slide-12

TBI-pathophysiology • Secondary injury

• Includes • Intracranial

hemorrhage • Swelling/ Edema • Hypoxia • Infection • Hydrocephalus • Hypotension • Seizures • Vasospasm

• Electrolyte

imbalances • Anemia • Hyperthermia • Hyper/hypo

glycemia • Hypercarbia • Hyponatremia • Carotid dissection

©2015 MFMER | slide-13

TBI- Blast injury • Primary injury

• Direct effects of the pressure (positive and negative) waves

• Secondary injury • Objects striking the person

• Tertiary injury • The person striking objects

• Quaternary injury • Associated injuries including inhalation, burns,

hypoxia

©2015 MFMER | slide-14

TBI- Predictors of Outcome • Definitions

• GCS • PTA

©2015 MFMER | slide-15

Glasgow Coma Scale

• Helps to define severity- best score in 24 hours

Score Motor (6) Verbal (5) Eye (4) 1 None None None 2 Extensor posturing

to pain Unintelligible Opens to pain

3 Flexor posturing to pain

Inappropriate Open to loud voice

4 Withdraws from pain

Confused Open spontaneously

5 Localize to pain Alert/oriented 6 Obey commands

©2015 MFMER | slide-16

Glasgow Coma Scale • 3-8- severe injury • 9-12- moderate injury • 13-15- mild injury

©2015 MFMER | slide-17

GCS as a predictor of outcome • Best motor response is best predictor • Total score predicting • Recent evidence indicates this may not predict

as well as previously thought.

©2015 MFMER | slide-18

Post traumatic amnesia

• Galveston Orientation and Amnesia Test (GOAT) • Assessed orientation, recall of circumstances, last pre-

injury and first post injury memories • 75 or greater for 2 consecutive days is end of PTA

Duration of PTA Severity of Injury Category

< 5 minutes Very mild 5-60 minutes Mild 1-24 hours Moderate 1-7 days Severe 1-4 weeks Very severe > 4 weeks Extremely severe

©2015 MFMER | slide-19

TBI- Other predictors • Imaging • Age • Pupillary reaction • SSEPs • Doll’s eye sign • Caloric testing • Motor response to pain • Time

©2015 MFMER | slide-20

TBI- outcome scales • Glasgow Outcome Scale

• 1-5 (1=death; 5=good recovery) • Disability Rating Scale

• 30 point scale (measures eye opening, verbalization/communication, motor responsiveness, feeding, toileting, grooming, overall level of functioning, employability)

• Functional Independence Measure (FIM) • 18-126 (cognitive and motor domains)

©2015 MFMER | slide-21

TBI - Disorders of Consciousness Sleep/wake cycles

Eye opening

Visual tracking

Evidence of environmental awareness

Consistent command following

Functional object use/ use of a communication system

Coma No No No No No No Vegetative state

Yes Yes No No No No

Minimal conscious state

Yes Yes Yes Yes No No

Emergence Yes Yes Yes Yes Yes Yes

Response to

©2015 MFMER | slide-22

TBI- Rancho Los Amigos Level Description I No response II Generalized response III Localized response IV Agitated V Confused and inappropriate VI Confused and appropriate VII Automatic and appropriate VIII Purposeful and appropriate

©2015 MFMER | slide-23

Neuropsychological testing • Assess cognitive and emotional issues which

may affect function.

©2015 MFMER | slide-24

Functional limitations secondary to TBI • Motor

• Impaired mobility • Impaired ADLs

• Behavior • Agitation • Disinhibition • Emotional lability • Abulia

• Social/cognitive • Return to work, school • Need for cognitive

supervision • Return to driving

©2015 MFMER | slide-25

Management of TBI associated complications

©2015 MFMER | slide-26

TBI- arousal • Sleep wake regulation • Fatigue • Medication options

• Stimulants • Dopaminergic agents

Giancino, 2012

©2015 MFMER | slide-27

Post traumatic agitation • Excessive psychomotor activity • Evaluate for underlying etiology • Education • Treatment

• Nonpharmacologic • Pharmacologic

• Monitor results of intervention

©2015 MFMER | slide-28

Treatment of post-traumatic agitation

Non-pharmacologic

• Environmental modification

• Education of staff/family

• Behavior modifications

Pharmacologic

• Beta-blockers

• Anti-convulsants

• Anti-psychotics

• Antidepressants

• Neuro-stimulants

• Dopaminergic agents

• Benzodiazepines

• Lithium

©2015 MFMER | slide-29

Post Traumatic Hydrocephalus • True hydrocephalus vs. ex vacuo changes • Symptoms

• Cognitive changes • Gait dysfunction • Urinary incontinence

• Evaluation • Imaging- CT head

• Treatment • Lumbar puncture • Shunting

©2015 MFMER | slide-30

Heterotopic Ossification • Formation of mature bone in soft tissue • Risks- neurologic injury, trauma, surgery, burns • Symptoms- pain, warmth, limited joint ROM • Evaluation- Triple phase bone scan • Treatment- physical therapy, NSAIDs,

bisphosphonates, radiation, surgery

©2015 MFMER | slide-31

Thromboembolic Disease • Risks- Virchow triad • Symptoms-

• DVT- none, fever, edema, warmth, pain • PE- none, chest pain, tachypnea/-cardia, hypoxia

• Evaluation- • DVT- venous US • PE- CT angio, VQ scan

• Treatment- • Anticoagulation, mechanical thrombectomy or

thrombolysis in select cases.

©2015 MFMER | slide-32

Post-traumatic Epilepsy/seizures • Immediate vs. early vs. late seizures • Risk factors • Prophylaxis • Treatment

©2015 MFMER | slide-33

Urinary dysfunction • Covered in detail elsewhere • Specific to brain injury

• Cortical lesions • Loss of inhibition

©2015 MFMER | slide-34

Endocrine complications • SIADH • Cerebral salt wasting • Diabetes Insipidus

©2015 MFMER | slide-35

SIADH DI CSW Fluid status Iso Iso (if able to match

fluids in/out) Dry

Sodium (serum) Low High Low Osmolality (serum) Low High Low Osmolality (urine) High Low Normal Treatment Fluid

restriction Desmopressin Fluid

supplementation

©2015 MFMER | slide-36

Spasticity • Upper motor neuron mediated velocity-

dependent increase in muscle tone • Examination- quantify spasticity • Treatment should be goal oriented • Treatment

• Stretching, splints and braces • Oral medications • Chemo-denervation • Intrathecal therapy • Surgery

©2015 MFMER | slide-37

Cognitive Rehabilitation • Focuses on difficulties with attention, learning or

memory, executive functioning • Remediation • Compensation

Cicerone, 2011

©2015 MFMER | slide-38

Mild TBI and concussion • Definition

• GCS 13-15 • +/- LOC (if present not to exceed 30 minutes) • PTA not exceeding 24 hours • Complicated if intracranial imaging findings on CT

day of injury

• Diagnosis • Clinical based on symptoms and exam

• Sideline testing • IMPACT and similar neuropsychologic profiles

©2015 MFMER | slide-39

Return to Play- concussion

Stage Activity 0-no activity (symptomatic) Cognitive/physical rest 1- light aerobic Intensity less than 70%; no

resistance training 2- sport-specific exercise Drills, no head impact activities 3- noncontact training drills More complex training drills,

progressive resistance training 4- Full-contact practice Participate in normal training 5- Return to play Normal game play

McCrory, 2013

©2015 MFMER | slide-40

Post-concussive syndrome • Multi-disciplinary approach

• Education • Symptom management

• Cognitive rehabilitation • Psychology/psychiatry • Headache/pain management • Sleep assessment/management • Vestibular rehabilitation • Vocational rehabilitation • Educational assistance

©2015 MFMER | slide-41

Chronic Traumatic Encephalopathy • Tauopathy of uncertain incidence, etiology and

clinical significance

©2015 MFMER | slide-42

Parkinson Disease • Cause- loss of substantia nigra pars compacta

(produces dopamine) and presence of Lewy bodies

• Symptoms • Rest tremor* • Bradykinesia* • Rigidity* • Hypophonia • Micrographia

• Parkinson Plus

©2015 MFMER | slide-43

Parkinson Plus Lewy Body Dementia

Progressive Supranuclear Palsy

Multiple System Atrophy

Corticobasal Degeneration

• Motor symptoms of PD

• Dementia (progressive)

• Visual hallucinations

• Motor symptoms of PD

• Decreased vertical gaze

• Bradykinesia • Rigidity • Ataxia • Autonomic

dysfunction

• Bradykinesia • Rigidity • Apraxia • Alien limb

syndrome

©2015 MFMER | slide-44

Parkinson Disease • A clinical diagnosis • Other associated symptoms/complications

• Dysphagia • Pain • Sexual dysfunction • Depression • Pulmonary dysfunction • Orthostasis

©2015 MFMER | slide-45

Medical treatment of Parkinson Disease • Medications

• Anticholinergic • Antiviral • Dopamine replacement • Dopamine agonist • Selective dopamine agonist • MAO B inhibitors • COMT inhibitors

• Surgical • Deep brain stimulator

©2015 MFMER | slide-46

Rehabilitation treatment of Parkinson Disease • Goals- improve muscle strength, mobility and

function • Gait training • Assessment of ADLs with adaptive

techniques/equipment • Speech pathology • Dysphagia assessment

©2015 MFMER | slide-47

Multiple Sclerosis • Inflammatory demyelinating disorder • 4 types

• Relapsing-remitting • Secondary progressive • Primary progressive • Progressive relapsing

• Diagnosis • Imaging • Clinical symptoms • Positive CSF

©2015 MFMER | slide-48

Multiple Sclerosis- symptoms

• Vision

• Sensory symptoms

• Motor symptoms

• Neurogenic bowel

• Neurogenic bladder

• Fatigue

• Sexual dysfunction

• Cranial nerve involvement

• Cerebellar symptoms

• Cognitive changes

• Mood disorders

©2015 MFMER | slide-49

Multiple Sclerosis- Medical Treatment • Treat the disease

• Immunomodulatory drugs • Antiproliferative drugs • Block extracellular processes

• Treat the symptoms • Spasticity • Fatigue • Pain • Neurogenic bladder/bowel • Mobility

©2015 MFMER | slide-50

Multiple Sclerosis- rehabilitation treatment • Dependent on symptoms • Goals- decrease spasticity, improve mobility,

improve function • Physical therapy • Occupational therapy • Speech and language pathology

©2015 MFMER | slide-51

Suggested Reading material • Textbooks

• General PMR • Braddom’s • DeLisa’s • Frontera’s

• Brain Injury • Zalser’s

©2015 MFMER | slide-52

References • [CDC | TBI Data and Statistics | Traumatic Brain Injury | Injury Center.

(2014, February 24). Retrieved September 21, 2015, from http://www.cdc.gov/traumaticbraininjury/data/index.html

• Giacino, J. T., Whyte, J., Bagiella, E., Kalmar, K., Childs, N., Khademi, A., . . . Eifert, B. (2012). Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain Injury. N Engl J Med, 366(9), 819-826.

• Cicerone, K., Langenbahn, D., Braden, C., Malec, J., Kalmar, K., Fraas, M., . . . Ashman, T. (2011). Evidence-Based Cognitive Rehabilitation: Updated Review of the Literature From 2003 Through 2008. Archives of Physical Medicine and Rehabilitation, 92, 519-530.

• McCrory, P., Meeuwisse, W., Aubry, M., Cantu, B., Dvorak, J., Echemendia, R., . . . Engebretsen, L. (2013). Consensus statement on Concussion in Sport- The 4th International Conference on Concussion in Sport held in Zurich, November 2012. Br J Sports Med, 47(5), 250-258.

©2015 MFMER | slide-53

Mayo Clinic Physical Medicine and Rehabilitation Board Review

Thank you for viewing this presentation.

For additional information on courses offered by the Mayo School of Continuous Professional Development

please visit ce.mayo.edu